1-20 of 58
Authors: Katherine B Peters
Save search
Sort by
Journal Article

Phase II randomized glioma study to evaluate efficacy and satisfaction of rolapitant plus ondansetron in preventing chemoradiation-induced nausea and vomiting Get access

PDF
Mary Lou Affronti and others
Neuro-Oncology Practice, npaf014, https://doi.org/10.1093/nop/npaf014
Published: 28 January 2025
Journal Article

Seizure risk factors and management approaches in patients with brain metastases Get access

PDF
Eugene J Vaios and others
Neuro-Oncology Practice, npaf001, https://doi.org/10.1093/nop/npaf001
Published: 13 January 2025
Journal Article
EDITOR'S CHOICE

The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma Get access

PDF
Macarena I de la Fuente and others
Neuro-Oncology, noae259, https://doi.org/10.1093/neuonc/noae259
Published: 25 December 2024
Journal Article

10311- ACT-19 A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH ADULT-TYPE DIFFUSE GLIOMA WITH AN IDH1/2 MUTATION (INDIGO): UPDATED EFFICACY RESULTS Open Access

PDF
Martin J Van Den Bent and others
Neuro-Oncology Advances, Volume 6, Issue Supplement_4, December 2024, Page iv9, https://doi.org/10.1093/noajnl/vdae173.035
Published: 29 November 2024
Journal Article

NIMG-77. MRI PHENOMENON OF PUNCTATE ENHANCING LESIONS IN PATIENTS TREATED WITH IDH INHIBITORS Free

PDF
Michal Nisnboym Ziv and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii213, https://doi.org/10.1093/neuonc/noae165.0841
Published: 11 November 2024
Journal Article

INNV-07. IVOSIDENIB AND BEVACIZUMAB IN HEAVILY PRETREATED PATIENTS WITH IDH1 MUTANT GLIOMAS Free

PDF
Mallika P Patel and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii170, https://doi.org/10.1093/neuonc/noae165.0670
Published: 11 November 2024
Journal Article

INNV-37. REAL-WORLD OUTCOMES AMONG HIGH GRADE IDH1-MUTANT GLIOMA PATIENTS TREATED WITH AN IDH INHIBITOR Free

PDF
Michal Nisnboym Ziv and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii176–viii177, https://doi.org/10.1093/neuonc/noae165.0698
Published: 11 November 2024
Journal Article

CTNI-53. A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH ADULT-TYPE DIFFUSE GLIOMA WITH AN IDH1/2 MUTATION (INDIGO): UPDATED EFFICACY RESULTS Free

PDF
Ingo K Mellinghoff and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii108–viii109, https://doi.org/10.1093/neuonc/noae165.0420
Published: 11 November 2024
Journal Article

CTIM-13. D2C7-IT IN COMBINATION WITH AN FC-ENGINEERED ANTI-HUMANCD40 MONOCLONAL ANTIBODY (2141-V11) ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOLLOWED BY CERVICAL PERILYMPHATIC INJECTIONS (CPLIS) OF 2141-V11 IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGBM) Free

PDF
Annick Desjardins and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii87, https://doi.org/10.1093/neuonc/noae165.0346
Published: 11 November 2024
Journal Article

CTNI-30. A PHASE 2 DOUBLE-BLIND, RANDOMIZED, PROSPECTIVE, PLACEBO CONTROLLED STUDY OF NANO₂TM COMBINED WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA: RESTORE Free

PDF
Michael A Badruddoja and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii102, https://doi.org/10.1093/neuonc/noae165.0397
Published: 11 November 2024
Journal Article

Practical management of patients with IDH-mutant glioma in the coming era of mIDH inhibitors: New drugs, new evidence, new guidelines, and new considerations Free

PDF
Katherine B Peters and Marjolein Geurts
Neuro-Oncology Practice, Volume 12, Issue Supplement_1, February 2025, Pages i2–i5, https://doi.org/10.1093/nop/npae076
Published: 19 October 2024
Journal Article

Symptom management in isocitrate dehydrogenase mutant glioma Free

PDF
Tobias Walbert and others
Neuro-Oncology Practice, Volume 12, Issue Supplement_1, February 2025, Pages i38–i48, https://doi.org/10.1093/nop/npae088
Published: 19 October 2024
Journal Article

Financial toxicity of oral chemotherapy in patients with primary brain tumors Get access

PDF
Mallika P Patel and others
Neuro-Oncology Practice, Volume 12, Issue 1, February 2025, Pages 153–159, https://doi.org/10.1093/nop/npae073
Published: 09 August 2024
Journal Article
EDITOR'S CHOICE

The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors? Open Access

PDF
Martin J van den Bent and others
Neuro-Oncology, Volume 26, Issue 10, October 2024, Pages 1805–1822, https://doi.org/10.1093/neuonc/noae107
Published: 24 June 2024
Journal Article

Use, access, and initial outcomes of off-label ivosidenib in patients with IDH1 mutant glioma Free

PDF
Katherine B Peters and others
Neuro-Oncology Practice, Volume 11, Issue 2, April 2024, Pages 199–204, https://doi.org/10.1093/nop/npad068
Published: 14 October 2023
Journal Article

Physician, patient, and caregiver support for a formal certification in pediatric neuro-oncology: A survey-based report from the SNO pediatrics working group Open Access

PDF
Holly B Lindsay and others
Neuro-Oncology Advances, Volume 5, Issue 1, January-December 2023, vdad130, https://doi.org/10.1093/noajnl/vdad130
Published: 09 October 2023
Journal Article

INDIGO: A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH RESIDUAL OR RECURRENT GRADE 2 GLIOMA WITH AN IDH1/2 MUTATION Free

PDF
Catherine McBain and others
Neuro-Oncology, Volume 25, Issue Supplement_3, October 2023, Page iii6, https://doi.org/10.1093/neuonc/noad147.025
Published: 16 September 2023
Journal Article

Long-term outcomes with reduced-dose whole-brain radiotherapy and a stereotactic radiosurgery boost for primary central nervous system lymphoma Open Access

PDF
Bronwen E Foreman and others
Neuro-Oncology Advances, Volume 5, Issue 1, January-December 2023, vdad097, https://doi.org/10.1093/noajnl/vdad097
Published: 03 August 2023
Journal Article

Clinical management of seizures in patients with meningiomas: Efficacy of surgical resection for seizure control and patient-tailored postoperative anti-epileptic drug management Open Access

PDF
Rodeania Peart and others
Neuro-Oncology Advances, Volume 5, Issue Supplement_1, May 2023, Pages i58–i66, https://doi.org/10.1093/noajnl/vdac136
Published: 03 June 2023
Journal Article

PATH-22. CLINICAL FEATURES AND MOLECULAR CHARACTERIZATION OF LEPTOMENINGEAL DISEASE IN PATIENTS WITH HIGH GRADE GLIOMA Free

PDF
Madison Shoaf and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii154–vii155, https://doi.org/10.1093/neuonc/noac209.595
Published: 14 November 2022